Compare PCRX & BHRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PCRX | BHRB |
|---|---|---|
| Founded | 2006 | 1852 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 999.0M | 968.8M |
| IPO Year | 2010 | 2023 |
| Metric | PCRX | BHRB |
|---|---|---|
| Price | $25.96 | $70.44 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 5 |
| Target Price | $30.25 | ★ $71.80 |
| AVG Volume (30 Days) | ★ 479.1K | 169.9K |
| Earning Date | 04-30-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 3.46% |
| EPS Growth | 107.44 | ★ 173.76 |
| EPS | 0.07 | ★ 1.79 |
| Revenue | ★ $541,533,000.00 | N/A |
| Revenue This Year | $6.78 | $36.62 |
| Revenue Next Year | $8.54 | $10.06 |
| P/E Ratio | $370.43 | ★ $39.54 |
| Revenue Growth | ★ 26.04 | N/A |
| 52 Week Low | $18.80 | $56.35 |
| 52 Week High | $27.64 | $73.69 |
| Indicator | PCRX | BHRB |
|---|---|---|
| Relative Strength Index (RSI) | 60.51 | 53.62 |
| Support Level | $21.89 | $61.32 |
| Resistance Level | $26.94 | $70.71 |
| Average True Range (ATR) | 0.82 | 1.60 |
| MACD | -0.03 | -0.25 |
| Stochastic Oscillator | 56.59 | 38.57 |
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.
Burke & Herbert Financial Services Corp is the bank holding company. Through its subsidiary, it predominantly serves small to medium-sized businesses, their owners and employees, professional corporations, non-profits, and individuals with various banking products and financial services. Some of its products and service offerings include checking, savings, and money market accounts, certificates of deposit, treasury and cash management services, commercial and industrial loans, commercial real estate loans, residential mortgage, acquisition, construction, and development loans, online banking, mobile banking, and wealth and trust services. The company operates in a single segment, namely Community Banking.